{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:02:10Z","timestamp":1761663730548,"version":"3.41.0"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T00:00:00Z","timestamp":1520208000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSC99-2320-B-002-011","MOST-105-2321-B-002-040"],"award-info":[{"award-number":["NSC99-2320-B-002-011","MOST-105-2321-B-002-040"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1007\/s00109-018-1626-9","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T12:40:54Z","timestamp":1520253654000},"page":"413-425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Dual immuno-renal targeting of 7-benzylidenenaltrexone alleviates lupus nephritis via Fc\u03b3RIIB and HO-1"],"prefix":"10.1007","volume":"96","author":[{"given":"Tsung-Chih","family":"Tseng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Duen-Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liang-Chuan","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haw","family":"Hwai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi-Wen","family":"Hsiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jyun-Pei","family":"Jhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric Y.","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shiang-Jong","family":"Tzeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,3,5]]},"reference":[{"key":"1626_CR1","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/bja\/aet153","volume":"111","author":"M Al-Hashimi","year":"2013","unstructured":"Al-Hashimi M, Scott SW, Thompson JP, Lambert DG (2013) Opioids and immune modulation: more questions than answers. Br J Anaesth 111:80\u201388","journal-title":"Br J Anaesth"},{"key":"1626_CR2","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1007\/s11481-006-9026-2","volume":"1","author":"JM Bidlack","year":"2006","unstructured":"Bidlack JM, Khimich M, Parkhill AL, Sumagin S, Sun B, Tipton CM (2006) Opioid receptors and signaling on cells from the immune system. J NeuroImmune Pharmacol 1:260\u2013269","journal-title":"J NeuroImmune Pharmacol"},{"key":"1626_CR3","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1146\/annurev.pa.36.040196.002115","volume":"36","author":"PA Zaki","year":"1996","unstructured":"Zaki PA, Bilsky EJ, Vanderah TW, Lai J, Evans CJ, Porreca F (1996) Opioid receptor types and subtypes: the delta receptor as a model. Annu Rev Pharmacol Toxicol 36:379\u2013401","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"1626_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0196-9781(95)02051-9","volume":"17","author":"RV House","year":"1996","unstructured":"House RV, Thomas PT, Bhargava HN (1996) A comparative study of immunomodulation produced by in vitro exposure to delta opioid receptor agonist peptides. Peptides 17:75\u201381","journal-title":"Peptides"},{"key":"1626_CR5","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/0304-3940(95)11983-4","volume":"198","author":"RV House","year":"1995","unstructured":"House RV, Thomas PT, Kozak JT, Bhargava HN (1995) Suppression of immune function by non-peptidic delta opioid receptor antagonists. Neurosci Lett 198:119\u2013122","journal-title":"Neurosci Lett"},{"key":"1626_CR6","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/0165-6147(93)90068-U","volume":"14","author":"JR Traynor","year":"1993","unstructured":"Traynor JR, Elliott J (1993) Delta-opioid receptor subtypes and cross-talk with mu-receptors. Trends Pharmacol Sci 14:84\u201386","journal-title":"Trends Pharmacol Sci"},{"key":"1626_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0014-2999(92)90167-3","volume":"218","author":"PS Portoghese","year":"1992","unstructured":"Portoghese PS, Sultana M, Nagase H, Takemori AE (1992) A highly selective delta 1-opioid receptor antagonist: 7-benzylidenenaltrexone. Eur J Pharmacol 218:195\u2013196","journal-title":"Eur J Pharmacol"},{"key":"1626_CR8","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/S0022-3565(24)29492-1","volume":"298","author":"C Gav\u00e9riaux-Ruff","year":"2001","unstructured":"Gav\u00e9riaux-Ruff C, Filliol D, Simonin F, Matthes HW, Kieffer BL (2001) Immunosuppression by delta-opioid antagonist naltrindole: delta- and triple mu\/delta\/kappa-opioid receptor knockout mice reveal a nonopioid activity. J Pharmacol Exp Ther 298:1193\u20131198","journal-title":"J Pharmacol Exp Ther"},{"key":"1626_CR9","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1172\/JCI118584","volume":"97","author":"S Takahashi","year":"1996","unstructured":"Takahashi S, Fossati L, Iwamoto M, Merino R, Motta R, Kobayakawa T, Izui S (1996) Imbalance towards Th1 predominance is associated with acceleration of lupus-like autoimmune syndrome in MRL mice. J Clin Invest 97:1597\u20131604","journal-title":"J Clin Invest"},{"key":"1626_CR10","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1097\/BOR.0b013e32832efff1","volume":"21","author":"H Bagavant","year":"2009","unstructured":"Bagavant H, Fu SM (2009) Pathogenesis of kidney disease in systemic lupus erythematosus. Curr Opin Rheumatol 21:489\u2013494","journal-title":"Curr Opin Rheumatol"},{"key":"1626_CR11","doi-asserted-by":"publisher","unstructured":"Tzeng SJ (2016) The isolation, differentiation, and quantification of human antibody-secreting B cells from blood: ELISpot as a functional readout of humoral immunity. J Vis Exp (118). https:\/\/doi.org\/10.3791\/54582","DOI":"10.3791\/54582"},{"key":"1626_CR12","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.coi.2017.03.003","volume":"45","author":"R Shinnakasu","year":"2017","unstructured":"Shinnakasu R, Kurosaki T (2017) Regulation of memory B and plasma cell differentiation. Curr Opin Immunol 45:126\u2013131","journal-title":"Curr Opin Immunol"},{"key":"1626_CR13","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/ni1151","volume":"6","author":"H Fukuyama","year":"2005","unstructured":"Fukuyama H, Nimmerjahn F, Ravetch JV (2005) The inhibitory Fc\u03b3 receptor modulates autoimmunity by limiting the accumulation of immunoglobulin G+ anti-DNA plasma cells. Nat Immunol 6:99\u2013106","journal-title":"Nat Immunol"},{"key":"1626_CR14","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/ni1440","volume":"8","author":"Z Xiang","year":"2007","unstructured":"Xiang Z, Cutler AJ, Brownlie RJ, Fairfax K, Lawlor KE, Severinson E, Walker EU, Manz RA, Tarlinton DM, Smith KG (2007) Fc\u03b3RIIb controls bone marrow plasma cell persistence and apoptosis. Nat Immunol 8:419\u2013429","journal-title":"Nat Immunol"},{"key":"1626_CR15","doi-asserted-by":"publisher","first-page":"5670","DOI":"10.4049\/jimmunol.180.8.5670","volume":"180","author":"TL McGaha","year":"2008","unstructured":"McGaha TL, Karlsson MC, Ravetch JV (2008) Fc\u03b3RIIB deficiency leads to autoimmunity and a defective response to apoptosis in Mrl-MpJ mice. J Immunol 180:5670\u20135679","journal-title":"J Immunol"},{"key":"1626_CR16","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s12929-015-0200-9","volume":"22","author":"SJ Tzeng","year":"2015","unstructured":"Tzeng SJ, Li WY, Wang HY (2015) Fc\u03b3RIIB mediates antigen-independent inhibition on human B lymphocytes through Btk and p38 MAPK. J Biomed Sci 22:87\u201398","journal-title":"J Biomed Sci"},{"key":"1626_CR17","doi-asserted-by":"publisher","first-page":"1681","DOI":"10.1681\/ASN.2007101099","volume":"19","author":"JH Kie","year":"2008","unstructured":"Kie JH, Kapturczak MH, Traylor A, Agarwal A, Hill-Kapturczak N (2008) Heme oxygenase-1 deficiency promotes epithelial-mesenchymal transition and renal fibrosis. J Am Soc Nephrol 19:1681\u20131691","journal-title":"J Am Soc Nephrol"},{"key":"1626_CR18","doi-asserted-by":"publisher","first-page":"1858","DOI":"10.1046\/j.1523-1755.2001.01000.x","volume":"60","author":"K Morimoto","year":"2001","unstructured":"Morimoto K, Ohta K, Yachie A, Yang Y, Shimizu M, Goto C, Toma T, Kasahara Y, Yokoyama H, Miyata T, Seki H, Koizumi S (2001) Cytoprotective role of heme oxygenase (HO)-1 in human kidney with various renal diseases. Kidney Int 60:1858\u20131866","journal-title":"Kidney Int"},{"key":"1626_CR19","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.05780616","volume":"12","author":"S Almaani","year":"2017","unstructured":"Almaani S, Meara A, Rovin BH (2017) Update on lupus nephritis. Clin J Am Soc Nephrol 12:825\u2013835","journal-title":"Clin J Am Soc Nephrol"},{"key":"1626_CR20","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1056\/NEJMra1100359","volume":"365","author":"GC Tsokos","year":"2011","unstructured":"Tsokos GC (2011) Systemic lupus erythematosus. N Engl J Med 365:2110\u20132121","journal-title":"N Engl J Med"},{"key":"1626_CR21","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1213\/01.ane.0000278865.11991.9d","volume":"105","author":"JP Williams","year":"2007","unstructured":"Williams JP, Thompson JP, McDonald J, Barnes TA, Cote T, Rowbotham DJ, Lambert DG (2007) Human peripheral blood mononuclear cells express nociceptin\/orphanin FQ, but not mu, delta, or kappa opioid receptors. Anesth Analg 105:998\u20131005","journal-title":"Anesth Analg"},{"key":"1626_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1093\/bja\/aev540","volume":"116","author":"M Al-Hashimi","year":"2016","unstructured":"Al-Hashimi M, McDonald J, Thompson JP, Lambert DG (2016) Evidence for nociceptin\/orphanin FQ (NOP) but not \u03bc (MOP), \u03b4 (DOP) or \u03ba (KOP) opioid receptor mRNA in whole human blood. Br J Anaesth 116:423\u2013429","journal-title":"Br J Anaesth"},{"key":"1626_CR23","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/nrrheum.2011.1","volume":"7","author":"F Hiepe","year":"2011","unstructured":"Hiepe F, D\u00f6rner T, Hauser AE, Hoyer BF, Mei H, Radbruch A (2011) Long-lived autoreactive plasma cells drive persistent autoimmune inflammation. Nat Rev Rheumatol 7:170\u2013178","journal-title":"Nat Rev Rheumatol"},{"key":"1626_CR24","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.jaut.2012.05.010","volume":"39","author":"IM Mumtaz","year":"2012","unstructured":"Mumtaz IM, Hoyer BF, Panne D, Moser K, Winter O, Cheng QY, Yoshida T, Burmester GR, Radbruch A, Manz RA, Hiepe F (2012) Bone marrow of NZB\/W mice is the major site for plasma cells resistant to dexamethasone and cyclophosphamide: implications for the treatment of autoimmunity. J Autoimmun 39:180\u2013188","journal-title":"J Autoimmun"},{"key":"1626_CR25","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrneph.2016.20","volume":"12","author":"F Hiepe","year":"2016","unstructured":"Hiepe F, Radbruch A (2016) Plasma cells as an innovative target in autoimmune disease with renal manifestations. Nat Rev Nephrol 12:232\u2013240","journal-title":"Nat Rev Nephrol"},{"key":"1626_CR26","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3389\/fimmu.2013.00494","volume":"4","author":"M Mah\u00e9vas","year":"2013","unstructured":"Mah\u00e9vas M, Michel M, Weill JC, Reynaud CA (2013) Long-lived plasma cells in autoimmunity: lessons from B-cell depleting therapy. Front Immunol 4:494\u2013498","journal-title":"Front Immunol"},{"key":"1626_CR27","doi-asserted-by":"crossref","first-page":"51","DOI":"10.4049\/jimmunol.160.1.51","volume":"160","author":"O Chan","year":"1998","unstructured":"Chan O, Shlomchik MJ (1998) A new role for B cells in systemic autoimmunity: B cells promote spontaneous T cell activation in MRL-lpr\/lpr mice. J Immunol 160:51\u201359","journal-title":"J Immunol"},{"key":"1626_CR28","doi-asserted-by":"crossref","first-page":"3592","DOI":"10.4049\/jimmunol.163.7.3592","volume":"163","author":"OT Chan","year":"1999","unstructured":"Chan OT, Madaio MP, Shlomchik MJ (1999) B cells are required for lupus nephritis in the polygenic, Fas-intact MRL model of systemic autoimmunity. J Immunol 163:3592\u20133596","journal-title":"J Immunol"},{"key":"1626_CR29","doi-asserted-by":"publisher","first-page":"35247","DOI":"10.1074\/jbc.M505308200","volume":"280","author":"SJ Tzeng","year":"2005","unstructured":"Tzeng SJ, Bolland S, Inabe K, Kurosaki T, Pierce SK (2005) The B cell inhibitory Fc receptor triggers apoptosis by a novel c-Abl family kinase-dependent pathway. J Biol Chem 280:35247\u201335254","journal-title":"J Biol Chem"},{"key":"1626_CR30","doi-asserted-by":"publisher","first-page":"1639","DOI":"10.1046\/j.1523-1755.1999.00425.x","volume":"55","author":"M Kitamura","year":"1999","unstructured":"Kitamura M, Fine LG (1999) The concept of glomerular self-defense. Kidney Int 55:1639\u20131671","journal-title":"Kidney Int"},{"key":"1626_CR31","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11906-009-0011-z","volume":"11","author":"T Jarmi","year":"2009","unstructured":"Jarmi T, Agarwal A (2009) Heme oxygenase and renal disease. Curr Hypertens Rep 11:56\u201362","journal-title":"Curr Hypertens Rep"},{"key":"1626_CR32","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1016\/S0272-6386(00)70256-3","volume":"35","author":"K Ohta","year":"2000","unstructured":"Ohta K, Yachie A, Fujimoto K, Kaneda H, Wada T, Toma T, Seno A, Kasahara Y, Yokoyama H, Seki H, Koizumi S (2000) Tubular injury as a cardinal pathologic feature in human heme oxygenase-1 deficiency. Am J Kidney Dis 35:863\u2013870","journal-title":"Am J Kidney Dis"},{"key":"1626_CR33","doi-asserted-by":"publisher","first-page":"e0147084","DOI":"10.1371\/journal.pone.0147084","volume":"11","author":"X Chen","year":"2016","unstructured":"Chen X, Wei SY, Li JS, Zhang QF, Wang YX, Zhao SL, Yu J, Wang C, Qin Y, Wei QJ, Lv GX, Li B (2016) Overexpression of heme oxygenase-1 prevents renal interstitial inflammation and fibrosis induced by unilateral ureter obstruction. PLoS One 11:e0147084","journal-title":"PLoS One"},{"key":"1626_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/j.1365-2249.2004.02594.x","volume":"138","author":"Y Takeda","year":"2004","unstructured":"Takeda Y, Takeno M, Iwasaki M, Kobayashi H, Kirino Y, Ueda A, Nagahama K, Aoki I, Ishigatsubo Y (2004) Chemical induction of HO-1 suppresses lupus nephritis by reducing local iNOS expression and synthesis of anti-dsDNA antibody. Clin Exp Immunol 138:237\u2013244","journal-title":"Clin Exp Immunol"},{"key":"1626_CR35","doi-asserted-by":"publisher","first-page":"F791","DOI":"10.1152\/ajprenal.00472.2011","volume":"302","author":"AA Elmarakby","year":"2012","unstructured":"Elmarakby AA, Faulkner J, Baban B, Saleh MA, Sullivan JC (2012) Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats. Am J Physiol Renal Physiol 302:F791\u2013F800","journal-title":"Am J Physiol Renal Physiol"},{"key":"1626_CR36","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0014-2999(94)90411-1","volume":"251","author":"J Kamei","year":"1994","unstructured":"Kamei J, Iwamoto Y, Suzuki T, Misawa M, Nagase H, Kasuya Y (1994) Involvement of delta 1-opioid receptor antagonism in the antitussive effect of \u03b4-opioid receptor antagonists. Eur J Pharmacol 251:291\u2013294","journal-title":"Eur J Pharmacol"},{"key":"1626_CR37","doi-asserted-by":"publisher","unstructured":"Abdallah K, Gendron L (2017, 2017 May 17) The delta opioid receptor in pain control. Handb Exp Pharmacol. https:\/\/doi.org\/10.1007\/164_2017_32","DOI":"10.1007\/164_2017_32"},{"key":"1626_CR38","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1097\/FBP.0b013e32834a1f2c","volume":"22","author":"C Gav\u00e9riaux-Ruff","year":"2001","unstructured":"Gav\u00e9riaux-Ruff C, Kieffer BL (2001) Delta opioid receptor analgesia: recent contributions from pharmacology and molecular approaches. Behav Pharmacol 22:405\u2013414","journal-title":"Behav Pharmacol"},{"key":"1626_CR39","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/jcpt.12244","volume":"40","author":"JF Peppin","year":"2015","unstructured":"Peppin JF, Raffa RB (2015) Delta opioid agonists: a concise update on potential therapeutic applications. J Clin Pharm Ther 40:155\u2013166","journal-title":"J Clin Pharm Ther"},{"key":"1626_CR40","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1111\/j.1460-9568.2006.04569.x","volume":"23","author":"X Nadal","year":"2006","unstructured":"Nadal X, Ba\u00f1os JE, Kieffer BL, Maldonado R (2006) Neuropathic pain is enhanced in delta-opioid receptor knockout mice. Eur J Neurosci 23:830\u2013834","journal-title":"Eur J Neurosci"},{"key":"1626_CR41","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1111\/j.1460-9568.2008.06223.x","volume":"27","author":"C Gav\u00e9riaux-Ruff","year":"2008","unstructured":"Gav\u00e9riaux-Ruff C, Karchewski LA, Hever X, Matifas A, Kieffer BL (2008) Inflammatory pain is enhanced in delta opioid receptor-knockout mice. Eur J Neurosci 27:2558\u20132567","journal-title":"Eur J Neurosci"},{"key":"1626_CR42","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.neuropharm.2013.08.028","volume":"76","author":"P Charbogne","year":"2014","unstructured":"Charbogne P, Kieffer BL, Befort K (2014) 15 years of genetic approaches in vivo for addiction research: opioid receptor and peptide gene knockout in mouse models of drug abuse. Neuropharmacology 76:204\u2013217","journal-title":"Neuropharmacology"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00109-018-1626-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-018-1626-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-018-1626-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T10:12:31Z","timestamp":1751451151000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00109-018-1626-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,5]]},"references-count":42,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["1626"],"URL":"https:\/\/doi.org\/10.1007\/s00109-018-1626-9","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"type":"print","value":"0946-2716"},{"type":"electronic","value":"1432-1440"}],"subject":[],"published":{"date-parts":[[2018,3,5]]},"assertion":[{"value":"21 September 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2017","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing financial interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}